Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/75291
Title: | Health-promoting bioactivity and in vivo genotoxicity evaluation of a hemiepiphyte fig, Ficus dubia |
Authors: | Uthaiwan Suttisansanee Pornsiri Pitchakarn Pisamai Ting Woorawee Inthachat Parunya Thiyajai Daraphan Rodthayoy Jirarat Karinchai Bhanumas Chanatarasuwan Onanong Nuchuchua Piya Temviriyanukul |
Authors: | Uthaiwan Suttisansanee Pornsiri Pitchakarn Pisamai Ting Woorawee Inthachat Parunya Thiyajai Daraphan Rodthayoy Jirarat Karinchai Bhanumas Chanatarasuwan Onanong Nuchuchua Piya Temviriyanukul |
Keywords: | Agricultural and Biological Sciences |
Issue Date: | 1-Apr-2021 |
Abstract: | Ficus species have been used as a typical component in food and folk medicine in Asia for centuries. However, little is known regarding the bioactivity and genotoxicity of the recently identified Ficus dubia (FD), an indigenous plant of the tropical evergreen rain forest. FD is unique from other Ficus species because of its highly sought-after red-brown latex. Antioxidant properties together with phenolic and flavonoid contents of FD were elucidated. Health-promoting characteristics were examined by studying the inhibition of enzymes as a drug target for diabetes, hypertension, Alzheimer's disease, and obesity, together with anticancer ability against human colorectal adenocarcinoma, human hepatocellular carcinoma, human ovarian carcinoma, human prostate adenocarcinoma, and human lung carcinoma. Besides, FD genotoxicity was tested using the Drosophila wing spot test. Results showed that both FD root and latex exhibited antioxidant activity due to the presence of phenolics and flavonoids, specifically caffeic acid and cyanidin. The ethanolic fraction of FD root demonstrated a potent antidiabetic mechanism underlying α-glucosidase inhibitory activity similar to acarbose. This fraction also suppressed lung and ovarian cancer growth, possibly by G1 and G2/M arrest, respectively. All tested fractions lacked mutagenicity in vivo. Results indicated that FD can be developed as novel antidiabetic compounds; however, its bioactive compounds should be further identified. |
URI: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101886464&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/75291 |
ISSN: | 20487177 |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.